TherapeuticsMD (TXMD) Revenue & Revenue Breakdown
TherapeuticsMD Revenue Highlights
Latest Revenue (Y)
$1.30M
Main Segment (Y)
License
TherapeuticsMD Revenue by Period
TherapeuticsMD Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.30M | -98.14% |
| 2022-12-31 | $69.96M | -19.54% |
| 2021-12-31 | $86.95M | 34.03% |
| 2020-12-31 | $64.87M | 30.67% |
| 2019-12-31 | $49.65M | 208.38% |
| 2018-12-31 | $16.10M | -4.04% |
| 2017-12-31 | $16.78M | -13.32% |
| 2016-12-31 | $19.36M | -3.90% |
| 2015-12-31 | $20.14M | 34.05% |
| 2014-12-31 | $15.03M | 71.23% |
| 2013-12-31 | $8.78M | 129.85% |
| 2012-12-31 | $3.82M | 82.84% |
| 2011-12-31 | $2.09M | 4230.79% |
| 2010-12-31 | $48.22K | 356.21% |
| 2009-12-31 | $10.57K | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | -100.00% |
| 2006-12-31 | $1.01M | 7.57% |
| 2005-12-31 | $934.52K | 50.26% |
| 2004-12-31 | $621.93K | 42.13% |
| 2003-12-31 | $437.59K | 52.68% |
| 2002-12-31 | $286.60K | -13.82% |
| 2001-12-31 | $332.57K | -9.63% |
| 2000-12-31 | $368.02K | 71.82% |
| 1999-12-31 | $214.19K | 10.42% |
| 1998-12-31 | $193.97K | 0.45% |
| 1997-12-31 | $193.10K | -20.88% |
| 1996-12-31 | $244.05K | 24.62% |
| 1995-12-31 | $195.83K | -0.48% |
| 1994-12-31 | $196.78K | -2.19% |
| 1993-12-31 | $201.18K | - |
TherapeuticsMD generated $1.30M in revenue during NA 2023, up -98.14% compared to the previous quarter, and up 8.09% compared to the same period a year ago.
TherapeuticsMD Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $313.00K | -37.65% |
| 2023-12-31 | $502.00K | -1047.17% |
| 2023-09-30 | $-53.00K | -112.13% |
| 2023-06-30 | $437.00K | 5.05% |
| 2023-03-31 | $416.00K | -63.89% |
| 2022-12-31 | $1.15M | -94.49% |
| 2022-09-30 | $20.92M | -26.76% |
| 2022-06-30 | $28.56M | 47.73% |
| 2022-03-31 | $19.33M | 3.51% |
| 2021-12-31 | $18.68M | -26.48% |
| 2021-09-30 | $25.41M | 10.46% |
| 2021-06-30 | $23.00M | 15.78% |
| 2021-03-31 | $19.87M | -12.01% |
| 2020-12-31 | $22.58M | 16.72% |
| 2020-09-30 | $19.34M | 80.76% |
| 2020-06-30 | $10.70M | -12.65% |
| 2020-03-31 | $12.25M | -22.96% |
| 2019-12-31 | $15.90M | -32.96% |
| 2019-09-30 | $23.72M | 290.20% |
| 2019-06-30 | $6.08M | 54.03% |
| 2019-03-31 | $3.95M | -22.46% |
| 2018-12-31 | $5.09M | 46.52% |
| 2018-09-30 | $3.47M | -7.69% |
| 2018-06-30 | $3.76M | -0.28% |
| 2018-03-31 | $3.77M | -8.51% |
| 2017-12-31 | $4.12M | -6.64% |
| 2017-09-30 | $4.42M | 3.93% |
| 2017-06-30 | $4.25M | 6.65% |
| 2017-03-31 | $3.99M | -11.19% |
| 2016-12-31 | $4.49M | -18.94% |
| 2016-09-30 | $5.54M | 25.72% |
| 2016-06-30 | $4.40M | -10.69% |
| 2016-03-31 | $4.93M | -12.43% |
| 2015-12-31 | $5.63M | 8.47% |
| 2015-09-30 | $5.19M | 7.06% |
| 2015-06-30 | $4.85M | 8.33% |
| 2015-03-31 | $4.48M | 5.11% |
| 2014-12-31 | $4.26M | 1.71% |
| 2014-09-30 | $4.19M | 11.58% |
| 2014-06-30 | $3.75M | 32.55% |
| 2014-03-31 | $2.83M | -1.13% |
| 2013-12-31 | $2.86M | 24.76% |
| 2013-09-30 | $2.29M | 10.28% |
| 2013-06-30 | $2.08M | 35.37% |
| 2013-03-31 | $1.54M | 23.90% |
| 2012-12-31 | $1.24M | 19.71% |
| 2012-09-30 | $1.04M | 26.53% |
| 2012-06-30 | $819.15K | 13.50% |
| 2012-03-31 | $721.69K | -65.40% |
| 2011-12-31 | $2.09M | 99237.00% |
| 2011-09-30 | $2.10K | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | -100.00% |
| 2010-12-31 | $20.36K | -7.94% |
| 2010-09-30 | $22.12K | 285.77% |
| 2010-06-30 | $5.73K | -62.59% |
| 2010-03-31 | $15.33K | 45.04% |
| 2009-12-31 | $10.57K | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
TherapeuticsMD generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
TherapeuticsMD Revenue Breakdown
TherapeuticsMD Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 18 |
|---|---|---|---|---|
| License | $1.30M | $69.96M | $1.17M | - |
| Prescription Vitamins | - | - | $5.72M | $15.04M |
| Annovera | - | - | $37.94M | - |
| Product | - | - | $85.78M | - |
| IMVEXXY R | - | - | - | $1.06M |
TherapeuticsMD's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Jun 19 | Mar 19 | Dec 18 | Sep 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License and Service | $234.00K | $313.00K | $416.00K | - | - | - | - | - | - | - | - | - | - | - |
| Product | - | - | - | $20.92M | $28.50M | $18.91M | $18.68M | $24.47M | $23.00M | $19.63M | - | - | - | - |
| Prescription Vitamins | - | - | - | $892.00K | $904.00K | $875.00K | $1.50M | $1.35M | $1.45M | $1.43M | $2.82M | $1.94M | $4.24M | $3.26M |
| License And Service | - | - | - | - | $65.00K | $419.00K | - | - | - | - | - | - | - | - |
| Imvexxy | - | - | - | $6.95M | $6.67M | $9.84M | - | - | - | - | - | - | - | - |
| Annovera | - | - | - | $10.41M | $18.27M | $8.51M | $7.83M | $11.81M | $9.55M | - | - | - | - | - |
| License | - | - | - | - | - | - | - | $937.00K | - | $234.00K | - | - | - | - |
| Bijuva | - | - | - | - | - | - | - | - | $2.16M | - | - | - | - | - |
| ANNOVERA | - | - | - | - | - | - | - | - | - | $8.75M | - | - | - | - |
| BIJUVA | - | - | - | - | - | - | - | - | - | $2.44M | $134.28K | - | - | - |
| IMVEXXY | - | - | - | - | - | - | - | - | - | $7.01M | $3.12M | $2.01M | - | - |
| IMVEXXY R | - | - | - | - | - | - | - | - | - | - | - | - | $846.13K | - |
| IMVEXXY TM | - | - | - | - | - | - | - | - | - | - | - | - | - | $212.08K |
TherapeuticsMD's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: License and Service (100.00%).
TherapeuticsMD Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Jun 19 | Mar 19 | Dec 18 | Sep 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License and Service | $416.00K | - | - | - | - | - | - | - | - | - | - | - |
| Product | - | $20.92M | $28.50M | $18.91M | $18.68M | $24.47M | $23.00M | $19.63M | - | - | - | - |
| Annovera | - | $10.41M | $18.27M | $8.51M | $7.83M | $11.81M | $9.55M | - | - | - | - | - |
| Prescription Vitamins | - | $892.00K | $904.00K | $875.00K | $1.50M | $1.35M | $1.45M | $1.43M | $2.82M | $1.94M | $4.24M | $3.26M |
| License And Service | - | - | $65.00K | $419.00K | - | - | - | - | - | - | - | - |
| Imvexxy | - | $6.95M | $6.67M | $9.84M | - | - | - | - | - | - | - | - |
| License | - | - | - | - | - | $937.00K | - | $234.00K | - | - | - | - |
| Bijuva | - | - | - | - | - | - | $2.16M | - | - | - | - | - |
| IMVEXXY | - | - | - | - | - | - | - | $7.01M | $3.12M | $2.01M | - | - |
| BIJUVA | - | - | - | - | - | - | - | $2.44M | $134.28K | - | - | - |
| ANNOVERA | - | - | - | - | - | - | - | $8.75M | - | - | - | - |
| IMVEXXY R | - | - | - | - | - | - | - | - | - | - | $846.13K | - |
| IMVEXXY TM | - | - | - | - | - | - | - | - | - | - | - | $212.08K |
TherapeuticsMD's latest quarterly revenue breakdown by geography, as of Mar 23: License and Service (100.00%).
TherapeuticsMD Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.39M |
| ALKS | Alkermes | $1.66B | $399.13M |
| ANIP | ANI Pharmaceuticals | $486.82M | $138.04M |
| IRWD | Ironwood Pharmaceuticals | $442.74M | $94.40M |
| ORGO | Organogenesis | $433.14M | $130.23M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| LFCR | Lifecore Biomedical | $128.26M | $24.70M |
| AQST | Aquestive Therapeutics | $50.58M | $20.10M |
| CPIX | Cumberland Pharmaceuticals | $39.55M | $9.85M |
| TKNO | Alpha Teknova | $36.68M | $9.61M |
| AGRX | Agile Therapeutics | $19.59M | $5.58M |
| GHSI | Guardion Health Sciences | $12.25M | $36.35K |
| EVOK | Evoke Pharma | $5.18M | $1.74M |
| ADMP | Adamis Pharmaceuticals | $4.76M | $9.06M |
| TXMD | TherapeuticsMD | $1.30M | - |
| CYTH | Cyclo Therapeutics | $1.08M | $123.10K |
| ACRX | Talphera | $651.00K | $117.00K |
| PRFX | PainReform | - | - |
TXMD Revenue FAQ
What is TherapeuticsMD’s yearly revenue?
TherapeuticsMD's yearly revenue for 2023 was $1.3M, representing a decrease of -98.14% compared to 2022. The company's yearly revenue for 2022 was $69.96M, representing a decrease of -19.54% compared to 2021. TXMD's yearly revenue for 2021 was $86.95M, representing an increase of 34.03% compared to 2020.
What is TherapeuticsMD’s quarterly revenue?
TherapeuticsMD's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $313K, a -37.65% decrease from the previous quarter (Q4 2023), and a -24.76% decrease year-over-year (Q1 2023). TXMD's quarterly revenue for Q4 2023 was $502K, a -1047.17% decrease from the previous quarter (Q3 2023), and a -56.42% decrease year-over-year (Q4 2022).
What is TherapeuticsMD’s revenue growth rate?
TherapeuticsMD's revenue growth rate for the last 3 years (2021-2023) was -98.50%, and for the last 5 years (2019-2023) was -97.38%.
What are TherapeuticsMD’s revenue streams?
TherapeuticsMD's revenue streams in c 23 are License
What is TherapeuticsMD’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of TherapeuticsMD was License. This segment made a revenue of $1.3M, representing 100.00% of the company's total revenue.